Convalesce Inc
Regenerating neurons, restoring lives
- Employees
- 1–10
- Founded
- 2018
- Business Model
- B2B
- Website
- convalesce.co
- Total Funding
- $500K
- Last Round
- $250K SeedSep 2018
About
Convalesce is developing a stem cell-based therapy for neurological conditions like Parkinson's disease. Their core innovation is AmGel, a brain-mimetic hydrogel matrix that improves stem cell survival by 300% post-transplantation and confines cells to the target area. The gel's nanoscale topography mimics the brain's extracellular matrix, guiding stem cell differentiation into target neuron types.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account